CTSA Program Collaborative Innovation Awards: updates

February 7, 2018

Notice of Change of Application Due Date to PA-16-328 "Limited Competition: Administrative Supplements to Enhance Network Capacity: Collaborative Opportunities for the CTSA Program (Admin Supp)" 

Learn more

The purpose of this Notice is to change the Key Dates in PA-16-328, "Limited Competition: Administrative Supplements to Enhance Network Capacity: Collaborative Opportunities for the CTSA Program (Admin Supp)" to remove the March 1, 2018 receipt and July, 2018 award date.

Questions? Contact Erica Rosemond, Erica.Rosemond@nih.gov


Notice of Modifications for PAR-18-244 "Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01 Clinical Trial Optional)" 

Learn more

The purpose of this Notice is make modifications for PAR-18-244 "Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01 Clinical Trial Optional)" for March 8, 2018 and subsequent due dates, to expand the list of high priority translational research opportunities to conduct novel clinical research studies intended to develop and test models of care for Opioid Use Disorders within medical settings including primary care, emergency departments, and neo-natal units. 

In addition, this research provides the opportunity to explore many translational science barriers: how to recruit and retain difficult to reach populations, harnessing technology to simultaneously deliver effective care and facilitate the conduct of research, and integrating research into the workflow of busy clinical settings, etc. 

Partnerships between CTSA Program hubs and affiliates in rural areas of the country most impacted by the opioid epidemic including the North East, the Appalachian Region, and New Mexico, as well as partnerships with NIDA Clinical Trials Network Nodes (https://www.drugabuse.gov/about-nida/organization/cctn/ctn/network-organization/nodes) in these regions are of strong programmatic interest.  

Please see the notice for some examples of additional high priority opportunities.

Questions?  Contact PJ Brooks, PJ.Brooks@nih.gov